Search Results 691-700 of 18341 for prednisone

  1. Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects - Mayo Clinic

    corticosteroids (i.e., > 10 mg/day prednisone or equivalent) or other immunosuppressant therapy. - Current or history of any clinically significant medical ...

  2. Fludrocortisone (oral route) - Side effects & dosage - Mayo Clinic

    Fludrocortisone is a corticosteroid (cortisone-like medicine). It belongs to the family of medicines called steroids. Your body naturally produces similar ...

  3. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Patients treated with dexamethasone \> 2 mg/day or equivalent (i.e. 13 mg/day of prednisone, or 53 mg/day of hydrocortisone) within 14 days before the first ...

  4. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

    Systemic therapy with corticosteroids at >20 mg/day prednisone or equivalent within 1 week prior to the first dose of study drug. Subject has a history of ...

  5. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study - Mayo Clinic

    nivolumab/cabozantinib treatment. - Participants must not have active autoimmune disease requiring systemic steroids (equivalent of > 10mg of prednisone) or ...

  6. Belimumab in Remission of VASculitis - Clinical Trials

    Remission is defined as a Birmingham Vasculitis Activity (BVAS) score of 0 and receiving less than 10 mg/day of oral prednisone (or equivalent) on 2 consecutive ...

  7. Tacrolimus (topical route) - Mayo Clinic

    Atopic dermatitis is a skin condition where there is itching, redness, and inflammation, much like an allergic reaction. Tacrolimus helps to suppress these ...

  8. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    ... prednisone within 30 days before the first dose of study treatment on W1D1: Subjects who are currently receiving steroids at a prednisone-equivalent dose of ...

  9. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Systemic therapy with corticosteroids at >20 mg/day prednisone or equivalent within 1 week prior to the first dose of study drug. History of prior ...

  10. A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens - Mayo Clinic

    Taking chronic steroids (equivalent equal to or greater then 5mg of prednisone daily). Inclusion Criteria - For parents filling out the survey: Child with ...